Challenges and Opportunities in the Transplant Patient: Focus on Improving Care for CMV Infection

The goal of this activity is to provide clinicians with expert guidance on the prevention and management of CMV infection and disease.

This activity can be accessed using the following URL: https://www.medscape.org/viewarticle/948047

Support Statement
This activity is supported by an educational grant from Merck Inc. and Takeda.

Target Audience

This activity is intended for hematologists/oncologists, transplant surgeons, infectious disease specialists, nurses, pharmacists and all providers who care for patients at risk for post-transplant cytomegalovirus (CMV) infection.

Learning Objectives

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Real-world data on the use of newer therapies in the prevention of CMV
    • Data for emerging therapies for management of resistant/refractory CMV
  • Have greater competence related to
    • Developing a strategy for the prevention of CMV among hematopoietic stem cell transplant recipients
    • Developing a management strategy in the context of resistant or refractory CMV
Additional information

Contact

Name: 
Sherry Fisher
Phone Number: 
+1 (414) 805-0687
Email: 
slfisher@mcw.edu
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
Course opens: 
02/11/2021
Course expires: 
02/12/2022
Cost:
$0.00

 

 

Disclosures

As organizations accredited by the ACCME, the Medical College of Wisconsin and Medscape, LLC, require everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

  • Camille Nelson Kotton, MD

    Clinical Director
    Transplant and Immunocompromised Host Infectious Diseases
    Massachusetts General Hospital
    Boston, Massachusetts

    Disclosure: Camille Nelson Kotton, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Hookipa; Merck; Roche Diagnostics; Takeda
    Served as a speaker or a member of a speakers bureau for: Roche Diagnostics

  • Francisco M. Marty, MD

    Associate Professor of Medicine
    Harvard Medical School
    Associate Physician
    Brigham and Women's Hospital
    Boston, Massachusetts

    Disclosure: Francisco M. Marty, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AlloVir; Amplyx; Avir; F2G; Gilead; Janssen; Kyorin; Merck; Regeneron; ReViral; Symbio; United Medical
    Received grants for clinical research from: Amplyx; Ansun; Chimerix; Cidara; F2G; Gilead; Merck; Regeneron; Scynexis; Takeda; WHISCON

  • Genovefa Papanicolaou, MD

    Director
    Clinical Trials
    Infectious Disease Service
    Memorial Sloan Kettering Cancer Center
    Weill Cornell Medicine
    New York, New York

    Disclosure: Genovefa A. Papanicolaou, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: ADMA Biologics; Astellas; Cidara; Merck; Octapharma; Partner Therapeutics; Siemens; Shionogi
    Received grants for clinical research from: Astellas; Merck & Co.; Takeda
    Other: Allovir; Amplyz; DSMC; EAC Octapharma

Editor

  • Maria B. Uravich, BSc, ELS

    Senior Medical Education Director, Medscape, LLC

    Disclosure: Maria B. Uravich, BSc, ELS, has disclosed no relevant financial relationships.

CME, CE Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

Reviewer

  • Bronwen E. Shaw, MD, PhD

    Disclosure: Bronwen E. Shaw, MD, PhD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Orca bio; Therakos
    Received honorarium from: Therakos
    Additional Disclosure: CIBMTR receives financial support from the government, foundations and industry entities listed below to support broad research and educational missions. These funding sources are disclosed for transparency. Scientific and administrative review processes prevent direct influence of the funding sources to the CIBMTR scientific research agenda and individual research products and findings.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc., and Merk & co., Inc.

Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education to physicians.
 
Credit Designation Statement:
The Medical College of Wisconsin designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
 
Providership
This CME activity is co-provided by The Medical College of Wisconsin and PER, Physician Education Resource, LLC.

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$0.00
Please login or register to take this course.